Previous close | 0.0102 |
Open | 0.0102 |
Bid | 0.0002 x 0 |
Ask | 0.0164 x 0 |
Day's range | 0.0102 - 0.0102 |
52-week range | 0.0036 - 0.0172 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On April 8, 2024, Prem Watsa (Trades, Portfolio)'s firm, Fairfax Financial Holdings, made a notable adjustment to its investment portfolio by reducing its stake in Crescent Capital BDC Inc (NASDAQ:CCAP). This move had a -0.31% impact on the portfolio, leaving the firm with a total of 1,824,805 shares in CCAP, which now represents 2.13% of the portfolio and 4.90% of the firm's holdings in the traded stock. Prem Watsa (Trades, Portfolio), the founder and leader of Fairfax Financial Holdings, is a renowned figure in the investment world.
Crescent Capital BDC (CCAP) closed at $17 in the latest trading session, marking a -1.05% move from the prior day.
Based on the average brokerage recommendation (ABR), Crescent Capital BDC (CCAP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?